Industry › Healthcare & Pharm
Press Releases
Eisai's "URECE(R)" (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
Eisai
Dec 11, 2024 13:45 HKT/SGT
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
China Medical System Holdings Ltd.
Dec 09, 2024 14:00 JST
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
China Medical System Holdings Ltd.
Dec 09, 2024 13:00 HKT/SGT
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day
LAC Global
Dec 04, 2024 14:30 HKT/SGT
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
Everest Medicines Limited
Dec 04, 2024 11:08 HKT/SGT
雲頂新耀宣佈治療原發性膜性腎病的新型BTK抑制劑EVER001在1b/2a期臨床試驗階段性數據中取得積極結果
Everest Medicines Limited
Dec 04, 2024 10:59 HKT/SGT
云顶新耀宣布治疗原发性膜性肾病的新型BTK抑制剂EVER001在1b/2a期临床试验阶段性数据中取得积极结果
Everest Medicines Limited
Dec 04, 2024 10:48 HKT/SGT
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
China Medical System Holdings Ltd.
Dec 02, 2024 22:30 JST
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
China Medical System Holdings Ltd.
Dec 02, 2024 21:30 HKT/SGT
Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong
Everest Medicines Limited
Dec 02, 2024 10:34 HKT/SGT
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate
Hua Medicine
Nov 30, 2024 21:08 HKT/SGT
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC
Hua Medicine
Nov 30, 2024 20:34 HKT/SGT